Alpine Global Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-18,582
Closed -$67K 179
2022
Q4
$67K Buy
+18,582
New +$79.4K 0.02% 374
2022
Q1
Sell
-14,805
Closed -$131K 477
2021
Q4
$131K Buy
+14,805
New +$141K 0.02% 545
2021
Q3
Sell
-13,591
Closed -$143K 307
2021
Q2
$143K Sell
13,591
-208,739
-94% -$2.06M 0.02% 250
2021
Q1
$2.29M Buy
222,330
+172,330
+345% +$2.4M 0.22% 74
2020
Q4
$554K Buy
+50,000
New +$510K 0.11% 90

Other funds holding SRTA

Alpine Global Management's SRTA Position: Q1 2023 in Review

Alpine Global Management sold out of Strata Critical Medical Inc (SRTA) in Q1 2023, closing a stake of 18,582 shares — an estimated $67K sold.

Alpine Global Management first reported a position in SRTA in Q4 2020 and held it in 5 quarters. The position peaked at $2.29M in Q1 2021. 93 funds tracked by Wall St. Rank hold SRTA as of Q1 2023.

  • Alpine Global Management reported no remaining Strata Critical Medical Inc position as of Q1 2023 after selling out during the quarter.
  • Alpine Global Management sold 18,582 Strata Critical Medical Inc shares in Q1 2023, an estimated $67K.
  • Alpine Global Management first reported a position in Strata Critical Medical Inc in Q4 2020 and held it in 5 quarters.
  • Alpine Global Management's Strata Critical Medical Inc position peaked at $2.29M in Q1 2021.
  • 93 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2023.

Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.